46
Technology2h 57m ago

A preliminary case series suggested a potential association between late immunotherapy infusion timing and reduced pathological complete response (pCR) rates in early-stage Triple-Negative Breast Cancer (TNBC).

our institution

Who
patients with early-stage TNBC
What
A preliminary case series suggested a potential association between late immunotherapy infusion timing and reduced pathological complete response (pCR) rates in early-stage Triple-Negative Breast Cancer (TNBC).
When
Fri, 12 Jun 2026 22:36:17 GMT · 2h 57m ago
Where
our institution ·
Why
Emerging evidence suggests that the efficacy of immunotherapy may be influenced by the timing of drug administration, driven by circadian-regulated immune activity.
The Frontline Impact

How this affects you

The findings suggest that the timing of immunotherapy infusions could be a factor in treatment effectiveness for early-stage TNBC, potentially influencing recurrence rates and prompting further research into optimal scheduling for cancer therapies.

Story chain

2 events in this thread
  1. Currently Reading2h 57m ago
    A preliminary case series suggested a potential association between late immunotherapy infusion timing and reduced pathological complete response (pCR) rates in early-stage Triple-Negative Breast Cancer (TNBC).
  2. Technology2h 57m ago
    Early-day pembrolizumab may boost pCR and cut recurrences, prompting new scheduling questions.
    Open article

Verified Sources & Citations

Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.